The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

Authors: Norbert Müller, Markus Schwarz, Sandra Dehning, A. Douhe, Anja Cerovecki, B. Goldstein-Müller, Ilja Spellmann, Guenter Hetzel, Katja Maino, Nikolaus Kleindienst, H-J Möller, Volker Arolt, Michael Riedel - Molecular Psychiatry 2006 cited by 795